Saturday, November 14, 2026

EUR/CHF Bearish By 1% In The Last 10 Sessions

ViaNews Editorial Team

October 12, 2023

Automated market report from our archive (2020–2024), published before source-traceability. How we work

EUR/CHF Bearish By 1% In The Last 10 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 1.12% for the last 10 sessions. At 06:06 EST on Thursday, 12 October, EUR/CHF (EURCHF) is $0.96.

EUR/CHF's yearly highs and lows, it's 0.452% up from its 52-week low and 5.348% down from its 52-week high.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/CHF's Forex is considered to be overbought (>=80).

News about

  • Usd/jpy price analysis: struggles to capitalize on modest intraday bounce from one-week low. According to FXStreet on Tuesday, 10 October, "A sustained strength beyond could allow the USD/JPY pair to aim back to conquer the 150.00 psychological mark or the potential intervention level. ", "The latter should act as a key pivotal point, below which the USD/JPY pair is likely to accelerate the fall towards the 147.30 area, or the lowest level since September 14 touched last Tuesday. "
  • Usd/jpy price analysis: bulls await a breakout through one-week-old trading range, US CPI in focus. According to FXStreet on Thursday, 12 October, "The USD/JPY pair oscillates in a narrow trading band during the Asian session on Thursday and is currently placed just above the 149.00 mark, well within the striking distance of the weekly high touched the previous day.", "The momentum could get extended and push the USD/JPY pair closer to the 152.00 mark, or a multi-decade high touched in October 2022."
  • Usd/jpy oscillates at around 148.60 amidst dovish fed remarks, risk-on impulse. According to FXStreet on Tuesday, 10 October, "Nevertheless, the USD/JPY rally was capped by the US Treasury bond yields plunge as the 10-year benchmark note sits at 4.632%, dropping 17 basis points since Monday."

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com